Home > News > pSivida's biosilicon does its job, then goes away
May 27th, 2005
pSivida's biosilicon does its job, then goes away
Abstract:
Howard Lovy: Every one of pSivida's first "customers," are going to die. And they're going to die of the disease that the Australian nanobio company's product is designed to treat. But if BrachySil, the company's lead product, gives liver cancer patients the gift of another year of life without the pain of chemotherapy, then that would count as pSivida's first success.
Source:
Howard Lovy's NanoBot
Bookmark:
Nanomedicine
Nanotechnology could help fight diabetes: Injectable nanogel can monitor blood-sugar levels and secrete insulin when needed May 16th, 2013
Nanobiotix Revenue for the 1st quarter of 2013 May 15th, 2013
Pitt Chemists Demonstrate Nanoscale Alloys So Bright They Could Have Potential Medical Applications: “Think about a particle that will not only help researchers detect cancer sooner but be used to treat the tumor, too.” May 15th, 2013
Using clay to grow bone: Researchers use synthetic silicate to stimulate stem cells into bone cells May 15th, 2013